400 related articles for article (PubMed ID: 27743816)
21. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
22. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
[TBL] [Abstract][Full Text] [Related]
23. Development of Late Stent Malapposition After Paclitaxel-Coated Balloon Angioplasty for In-Stent Neoatherosclerosis.
Yumoto K; Watanabe T; Fukuzawa T; Hanaki Y; Aoki H; Kato K
JACC Cardiovasc Interv; 2015 Aug; 8(10):e167-e169. PubMed ID: 26315752
[No Abstract] [Full Text] [Related]
24. Neointimal hemorrhage after drug-eluting stent implantation: possible role for development of neoatherosclerosis.
Hao H; Fujii K; Imanaka T; Kawakami R; Kawano T; Takayama T; Hirayama A; Ishibashi-Ueda H; Masuyama T; Hirota S
JACC Cardiovasc Interv; 2014 Oct; 7(10):1196-7. PubMed ID: 25240549
[No Abstract] [Full Text] [Related]
25. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
26. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
27. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
[TBL] [Abstract][Full Text] [Related]
28. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
Nicol P; Hoppman P; Euller K; Xhepa E; Lenz T; Rai H; Jinnouchi H; Bulin A; Castellanos MI; Lahmann AL; Koppara T; Kastrati A; Joner M
Int J Cardiovasc Imaging; 2021 Jan; 37(1):25-35. PubMed ID: 32761285
[TBL] [Abstract][Full Text] [Related]
29. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
Rheude TA; Xhepa E; Byrne RA
Catheter Cardiovasc Interv; 2017 May; 89(6):E181-E184. PubMed ID: 27527355
[TBL] [Abstract][Full Text] [Related]
30. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
Lu WD; Huang CW; Li YH; Chen JY
JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
[No Abstract] [Full Text] [Related]
31. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
32. Neovascular microchannels in sirolimus-eluting stent occlusion at late phase.
Takano M; Yamamoto M; Seino Y; Mizuno K
JACC Cardiovasc Interv; 2010 Nov; 3(11):1202-3. PubMed ID: 21087758
[No Abstract] [Full Text] [Related]
33. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
34. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
[TBL] [Abstract][Full Text] [Related]
35. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
[TBL] [Abstract][Full Text] [Related]
36. Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation.
Zhang DM; Chen SL
J Cardiovasc Pharmacol; 2021 Sep; 78(3):388-393. PubMed ID: 34029271
[TBL] [Abstract][Full Text] [Related]
37. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
[TBL] [Abstract][Full Text] [Related]
38. Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.
Lemos PA; Abizaid AA; Meireles GC; Sarmento-Leite R; Prudente M; Cantarelli M; Dourado AD; Mariani J; Perin MA; Costantini C; Costa RA; Costa JR; Chamie D; Campos CA; Ribeiro E
Cardiovasc Ther; 2015 Dec; 33(6):367-71. PubMed ID: 26352896
[TBL] [Abstract][Full Text] [Related]
39. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
40. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
